Zai Lab Ltd

Common Name

Zai Lab

Country

China (Mainland)

Sector

Healthcare

Industry

Biotechnology

Employees

1,869

Ticker

9688

Exchange

HONG KONG EXCHANGES AND CLEARING LTD

Website

www.zailaboratory.com

Description

Zai Lab Limited is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies for oncology, autoimmune, infectious, and neurological diseases. Headquarte... Show more

Financial Statements of Zai Lab

Below are the financial statements of Zai Lab, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in thousands of USD	2024	2023
Current assets	—	—
Cash and cash equivalents	449,667^a	790,151^a
Restricted cash, current	100,000^a	0^a
Short-term investments	330,000^a	16,300^a
Accounts receivable (net of allowance for credit losses)	85,178^a	59,199^a
Notes receivable	4,233^a	6,134^a
Inventories, net	39,875^a	44,827^a
Prepayments and other current assets	41,527^a	22,995^a
Total current assets	1,050,480^a	939,606^a
Assets	—	—
Restricted cash, non-current	1,114^a	1,113^a
Long-term investments	3,115^a	9,220^a
Prepayments for equipment	18^a	111^a
Property and equipment, net	47,961^a	53,734^a
Operating lease right-of-use assets	21,496^a	14,844^a
Land use rights, net	2,907^a	3,069^a
Intangible assets, net	56,027^a	13,389^a
Long-term deposits	1,284^a	1,209^a
Value added tax recoverable	1,351^a	0^a
Total assets	1,185,753^a	1,036,295^a
Current liabilities	—	—
Accounts payable	100,906^a	112,991^a
Current operating lease liabilities	8,048^a	7,104^a
Short-term debt	131,711^a	0^a
Other current liabilities	58,720^a	82,972^a
Total current liabilities	299,385^a	203,067^a
Liabilities and shareholders’ equity	—	—
Deferred income	31,433^a	28,738^a
Non-current operating lease liabilities	13,712^a	8,047^a
Other non-current liabilities	325^a	325^a
Total liabilities	344,855^a	240,177^a
Shareholders’ equity	—	—
Ordinary shares	7^a	6^a
Additional paid-in capital	3,264,295^a	2,975,302^a
Accumulated deficit	-2,453,083^a	-2,195,980^a
Accumulated other comprehensive income	50,515^a	37,626^a
Treasury stock	-20,836^a	-20,836^a
Total shareholders’ equity	840,898^a	796,118^a
Total liabilities and shareholders’ equity	1,185,753^a	1,036,295^a

Verified Sources Behind Zai Lab’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Zai Lab’s data sources below and access millions more through our Disclosure Search.

a. Zai Lab's Annual Report 2024

Trace every data point back to Zai Lab’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Zai Lab Ltd

Financial Statements of Zai Lab

Verified Sources Behind Zai Lab’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

WuXi Biologics (Cayman) Inc

Pharmaron Beijing Co Ltd

Akeso Inc

Genscript Biotech Corp

Joincare Pharmaceutical Group Industry Co Ltd

Tasly Pharmaceutical Group Co Ltd